Attrition of HIV-infected individuals not yet eligible for antiretroviral treatment: Do we care?

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 104, Issue 10, 2010, Pages 690-692

  Van Griensven, Johan ^a   Sopheak, Thai ^b   Aseffa, Yibeltal ^c   Van Damme, Wim ^a   Lynen, Lutgarde ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b Sihanouk Hospital Center of HOPE   (Cambodia)

^c FEDERAL MINISTRY OF HEALTH   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; CAMBODIA; CD4 LYMPHOCYTE COUNT; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LETTER; OPPORTUNISTIC INFECTION; PATIENT CARE; SOCIOECONOMICS; TREATMENT OUTCOME; TUBERCULOSIS CONTROL;

ANTI-HIV AGENTS; CAMBODIA; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; PATIENT DROPOUTS;

EID: 77956652754     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2010.07.006     Document Type: Letter

References (9)

1. Tayler-Smith K., Zachariah R., Massaquoi M., Manzi M., Pasulani O., van den Akker T., et al. Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system?. Trans R Soc Trop Med Hyg 2010, 104:313-319.
2. Thai S., Koole O., Un P., Ros S., De Munter P., Van Damme W., et al. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Trop Med Int Health 2009, 14:1048-1058.
3. van Griensven J, Shumbusho F, Laurence D, Turate I, Price J., Patient Retention in Pre-ART Care at Rural Health Centers in Rwanda. Presented at the 4th Annual HIV and AIDS Research and Exchange Conference; 2-3 July 2008; Kigali, Rwanda; 2008. [accessed 17 July 2010]. http://www.cnls.gov.rw/pdf/recherche/abstract_book.pdf.
4. Iuliano D, Martson B, Miruko F, Muttai H, Williamson J, Brooks J, et al. Trends in Enrolment Characteristics of Patients at a Large HIV Clinic in Kenya 2003 to 2008: Implications for ART Guidelines. Presented at the17th Conference on Retroviruses and Opportunistic Infections, 16-19 February 2010; San Francisco, USA; 2010. [accessed 17 July 2010]. http://retroconference.org/2010/Abstracts/37978.htm.
5. Lawn S.D., Myer L., Edwards D., Bekker L.G., Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009, 23:1717-1725.
6. Granich R.M., Gilks C.F., Dye C., De Cock K.M., Williams B.G. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373:48-57.
7. Hallett T.B., Gregson S., Dube S., Garnett G.P. The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med 2008, 5:e53.
8. WHO. Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings. Geneva: World Health Organization: 2008. [accessed 17 July 2010]. http://www.who.int/hiv/pub/plhiv/interventions/en/index.html.
9. Losina E., Toure H., Uhler L.M., Anglaret X., Paltiel A.D., Balestre E., et al. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Cote d'Ivoire appraisal. PLos Med 2009, 6:e1000173.